Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ironwood Pharmaceuticals (IRWD) Notes Payables (2016 - 2019)

Historic Notes Payables for Ironwood Pharmaceuticals (IRWD) over the last 5 years, with Q2 2019 value amounting to $48.8 million.

  • Ironwood Pharmaceuticals' Notes Payables rose 9627.93% to $48.8 million in Q2 2019 from the same period last year, while for Jun 2019 it was $48.8 million, marking a year-over-year increase of 9627.93%. This contributed to the annual value of $47.6 million for FY2018, which is N/A changed from last year.
  • According to the latest figures from Q2 2019, Ironwood Pharmaceuticals' Notes Payables is $48.8 million, which was up 9627.93% from $46.0 million recorded in Q1 2019.
  • In the past 5 years, Ironwood Pharmaceuticals' Notes Payables ranged from a high of $48.8 million in Q2 2019 and a low of $8.4 million during Q3 2016
  • In the last 4 years, Ironwood Pharmaceuticals' Notes Payables had a median value of $25.0 million in 2015 and averaged $28.2 million.
  • Its Notes Payables has fluctuated over the past 5 years, first plummeted by 5822.77% in 2016, then skyrocketed by 28435.36% in 2019.
  • Over the past 4 years, Ironwood Pharmaceuticals' Notes Payables (Quarter) stood at $25.0 million in 2015, then plummeted by 66.33% to $8.4 million in 2016, then soared by 465.78% to $47.6 million in 2018, then rose by 2.61% to $48.8 million in 2019.
  • Its Notes Payables stands at $48.8 million for Q2 2019, versus $46.0 million for Q1 2019 and $47.6 million for Q4 2018.